Phenotypic and Molecular Characterization of Acinetobacter Baumannii and its Ability to Produce Beta-Lactamase Isolated from Different Clinical Samples in Diwaniyah Governorate

Mohammed Hassan Mzher  Muhaisen; Ameer Abed Kadhim  Al-Zeyadi

doi:10.17605/cajmns.v6i2.2749

Mohammed Hassan Mzher Muhaisen Al-Qadisiyah Education Directorate
Ameer Abed Kadhim Al-Zeyadi Al-Qadisiyah University / College of Dentistry

DOI: https://doi.org/10.17605/cajmns.v6i2.2749

Keywords: Acinetobacter Baumannii, Beta-Lactamase Production, Antibiotic Resistance, Molecular Characterization, PCR Detection, Nosocomial Infections

Abstract

Acinetobacter baumannii is an opportunistic bacterial pathogen responsible for a significant proportion of nosocomial infections, particularly in intensive care units. The bacterium’s multidrug resistance and ability to survive in hospital environments contribute to its persistence and pathogenicity. In Diwaniyah Governorate, limited studies have explored the phenotypic and molecular characteristics of A. baumannii, particularly its beta-lactamase production and antibiotic resistance. Identifying genetic markers associated with drug resistance is crucial for developing targeted antimicrobial strategies. Although previous research has investigated A. baumannii in different hospital settings, data on its molecular characterization and resistance profile in this region remain scarce. Understanding the prevalence of resistance genes, such as TEM-2 and blaOXA-51, can provide valuable insights into infection control measures. This study aimed to isolate and identify A. baumannii from clinical samples, determine its antibiotic resistance profile, and analyze the presence of beta-lactamase-producing genes using molecular techniques. Results: Of the 60 clinical samples, 20 (33%) were confirmed as A. baumannii. The highest isolation rate was from sputum (55%), followed by burns (45%) and wounds (15%). The rapid iodine test and Vitek 2 system confirmed that 85% of isolates produced beta-lactamase, exhibiting resistance to most antibiotics except Tigecycline. PCR analysis revealed that all isolates carried the 16S rRNA gene, 85% harbored the TEM-2 gene, and 50% contained the blaOXA-51 gene. This study is among the first to document the molecular profile of A. baumannii in Diwaniyah Governorate, highlighting its high resistance levels and genetic determinants of beta-lactamase production. Implications: The findings underscore the urgent need for continuous surveillance, stringent infection control protocols, and antimicrobial stewardship programs to combat the spread of drug-resistant A. baumannii in healthcare settings.

References

A. Y. Peleg, H. Seifert, and D. L. Paterson, "Acinetobacter baumannii: emergence of a successful pathogen," Clin. Microbiol. Rev., vol. 21, no. 3, pp. 538-582, 2008.

M. Safari, M. Saidijam, A. Bahador, R. Jafari, and M. Y. Alikhani, "High prevalence of multidrug resistance and metallo-beta-lactamase (MÎ²L) producing Acinetobacter Baumannii isolated from patients in ICU wards, Hamadan, Iran," J. Res. Health Sci., vol. 13, no. 2, pp. 162-167, 2013.

L. Dijkshoorn, C. P. Brouwer, S. J. Bogaards, A. Nemec, P. J. Van Den Broek, and P. H. Nibbering, "The synthetic N-terminal peptide of human lactoferrin, hLF (1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii," Antimicrob. Agents Chemother., vol. 48, no. 12, pp. 4919-4921, 2004.

M. H. M. Muhaisen, "Isolate and identification of bacteria in patients with cholecystitis and test for antibiotic sensitivity," Iraqi J. Hum. Soc. Sci. Res., vol. 3, no. 8S, 2023.

R. M. Abdullah, R. Z. T. Ahmed, and S. N. A. AL-Azzawi, "Genotyping of Acinetobacter baumannii by using BOX method," Indian J. Forensic Med. Toxicol., vol. 13, no. 4, 2019.

K. Lee, Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong, "Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp," J. Clin. Microbiol., vol. 41, no. 10, pp. 4623-4629, 2003.

T. Elhabibi and S. Ramzy, "Effect of antibiotic combinations on the sensitivity of carbapenem resistant Acinetobacter baumannii strains," J. Microb. Biochem. Technol., vol. 9, pp. 132-137, 2017.

J. G. Holt, N. R. Krieg, P. H. A. Sneath, J. T. Stanley, and S. T. Williams, Bergey's Manual of Determinative Bacteriology, 9th ed., Williams and Wilkins, Baltimore, USA, 1994.

M. Y. Al-Samaree and Z. M. Al-Khafaji, "Antibiogram of Acinetobacter baumannii isolated from Baghdad Hospitals," Int. J. Adv. Res. Biol. Sci., vol. 3, no. 4, pp. 238-242, 2016.

S. K. Ozdemir, J. Zhu, L. He, and L. Yang, "Direct estimation of Purcell factor from scatterer-induced mode splitting spectra of an optical microcavity," in Quantum Electronics and Laser Science Conference, May 2011, p. JTuI16, Optica Publishing Group.

A. Mavroidi, S. Likousi, E. Palla, M. Katsiari, Z. Roussou, A. Maguina, and E. D. Platsouka, "Molecular identification of tigecycline- and colistin-resistant carbapenemase-producing Acinetobacter baumannii from a Greek hospital from 2011 to 2013," J. Med. Microbiol., vol. 64, no. 9, pp. 993-997, 2015.

S. K. Ozdemir, J. Zhu, L. He, and L. Yang, "Direct estimation of Purcell factor from scatterer-induced mode splitting spectra of an optical microcavity," in Quantum Electronics and Laser Science Conference, May 2011, p. JTuI16, Optica Publishing Group.

L. Dijkshoorn, A. Nemec, and H. Seifert, "An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii," Nat. Rev. Microbiol., vol. 5, no. 12, pp. 939-951, 2007.

M. Kempf and J.-M. Rolain, "Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options," Int. J. Antimicrob. Agents, vol. 39, no. 2, pp. 105-114, 2012.